PUBLISHER: Data Bridge Market Research | PRODUCT CODE: 1102199
PUBLISHER: Data Bridge Market Research | PRODUCT CODE: 1102199
The global medication-assisted treatment (MAT) market is projected to register a substantial CAGR of 9.4% in the forecast period of 2022 to 2029. The new market report contains data for the historic year 2019, the base year of calculation is 2021, and the forecast period is 2022 to 2029.
Global Medication-Assisted Treatment (MAT) Market, By Type (Medication and Therapy), Products (Buprenorphine and Naloxone, Naltrexone, Buprenorphine, Methadone, Naloxone, Disulfiram, and Acamprosate), Drug Type (Generics and Branded), Dosage Form (Immediate Release and Extended Release), Route of Administration (Oral, Parenteral, and Others), Population Type (Adults and Teenage), End User (Rehabilitation Clinics, Hospitals, Specialty Centres, Homecare, and Others) Distribution Channel (Hospital Pharmacy, Direct Tender, Retail Pharmacy, Online Pharmacy, and Others), Country (Germany, France, U.K., Italy, Spain, Russia, Turkey, Belgium, Netherlands, Switzerland, Norway, Poland, Hungary, Lithuania, Austria, Ireland and Rest of Europe, China, Japan, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Vietnam and Rest of Asia-Pacific, South Africa, Saudi Arabia, UAE, Egypt, Israel, Kuwait and Rest of Middle East and Africa U.S., Canada, and Mexico and Rest of North America) Industry Trends and Forecast to 2029
High prevalence of opioid use disorder and alcohol use disorder
Increasing awareness of MAT
Indivior PLC
Orexo US Inc (a subsidiary of Orexo AB)
Recovery Centers of America
Alkermes
Sun Pharmaceutical Industries Ltd.
Purdue Pharma L.P.
Taj Pharmaceuticals Limited
Lannett
Hikma Pharmaceuticals PLC
Pfizer Inc.
Pinnacle Treatment Center
American Addiction Centers
Adamis Pharmaceuticals Corporation
Glenmark Pharmaceutical Inc.
Viatris Inc.
Mallinckrodt
Alvogen
Accord Healthcare
VistaPharm, Inc.
Teva Pharmaceutical Industries Ltd.
Dr. Reddy's Laboratories Ltd.
Amneal Pharmaceuticals LLC.
Titan Pharmaceuticals, Inc.